NOURIANZ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Kyowa Kirin, Inc.. The primary component is Istradefylline.
Product ID | 42747-604_3ddd489d-750a-4140-b2e2-de649564ed42 |
NDC | 42747-604 |
Product Type | Human Prescription Drug |
Proprietary Name | NOURIANZ |
Generic Name | Istradefylline |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-27 |
Marketing Category | NDA / NDA |
Application Number | NDA022075 |
Labeler Name | Kyowa Kirin, Inc. |
Substance Name | ISTRADEFYLLINE |
Active Ingredient Strength | 40 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-08-27 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA022075 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-08-27 |
Marketing Category | NDA |
Application Number | NDA022075 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-08-27 |
Ingredient | Strength |
---|---|
ISTRADEFYLLINE | 40 mg/1 |
SPL SET ID: | a7d008cb-b273-4049-a5d2-9c6902910d58 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
42747-602 | NOURIANZ | istradefylline |
42747-604 | NOURIANZ | istradefylline |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NOURIANZ 87086056 not registered Live/Pending |
KYOWA KIRIN CO., LTD. 2016-06-28 |